34 66

Cited 0 times in

Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis

Authors
 Oh Chan Kwon  ;  Jung Hwan Park  ;  Yong-Beom Park  ;  Min-Chan Park 
Citation
 ARTHRITIS RESEARCH & THERAPY, Vol.22(1) : 180, 2020-07 
Journal Title
 ARTHRITIS RESEARCH & THERAPY 
ISSN
 1478-6354 
Issue Date
2020-07
Keywords
Cardiovascular event ; Cardiovascular risk ; Methotrexate ; Takayasu arteritis
Abstract
Background: To identify disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis (TAK). Methods: Patients with TAK who fulfilled the American College of Rheumatology 1990 criteria for the classification of TAK and were followed up between 2006 and 2019 were included. Traditional cardiovascular risk factors and TAK disease-specific factors at the index date and incident cardiovascular events during the follow-up were retrospectively assessed. To estimate the risk of cardiovascular events according to TAK disease-specific factors, Cox regression analysis with adjustment for traditional cardiovascular risk factors was performed. Results: Of the total 207 patients with TAK, cardiovascular events occurred in 41 (19.8%) patients. Compared with patients who did not develop cardiovascular events, patients who developed cardiovascular events were older (38.5 ± 13.4 years vs. 43.6 ± 11.8 years, p = 0.028), more commonly had diabetes mellitus (6.6% vs. 19.5%, p = 0.029), had lower high-density lipoprotein cholesterol (57.3 ± 17.1 mg/dl vs. 51.2 ± 15.7 mg/dl, p = 0.040), more commonly had type V vascular involvement (33.1% vs. 63.4%, p 0.001), and less commonly received methotrexate (65.1% vs. 43.9%, p = 0.013). In Cox regression analysis, type V vascular involvement was significantly associated with increased risk of cardiovascular events (adjusted HR 2.852, 95% CI 1.474-5.518, p = 0.002), whereas the use of methotrexate was associated with reduced risk of cardiovascular events (adjusted HR 0.515, 95% CI 0.268-0.993, p = 0.047). Conclusion: Type V vascular involvement was associated with increased risk of cardiovascular events, while the use of methotrexate was associated with reduced risk of cardiovascular events, in patients with TAK.
Files in This Item:
T202003013.pdf Download
DOI
10.1186/s13075-020-02275-z
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kwon, Oh Chan(권오찬)
Park, Min Chan(박민찬) ORCID logo https://orcid.org/0000-0003-1189-7637
Park, Yong Beom(박용범)
Park, Jung Hwan(박정환)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/179494
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links